相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
Sajjan Mittal et al.
BLOOD (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma
Sattva S. Neelapu et al.
BLOOD (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4(+)CD25(-) T lymphocytes
Emilie Brillard et al.
EXPERIMENTAL HEMATOLOGY (2007)
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas:: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)
Roswitha Forstpointner et al.
BLOOD (2006)
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Susana Inoges et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses
Charles H. Redfern et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine
Matthew T. Hueman et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients
Andrea Anichini et al.
CANCER RESEARCH (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
W Hiddemann et al.
BLOOD (2005)
Treatment strategies in follicular lymphomas: Current status and future perspectives
W Hiddemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
I Hus et al.
LEUKEMIA (2005)
Fibromodulin, an extracellular matrix protein:: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
E Mikaelsson et al.
BLOOD (2005)
Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies
J Bae et al.
CLINICAL CANCER RESEARCH (2005)
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions
A Zingoni et al.
JOURNAL OF IMMUNOLOGY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination:: A phase I trial in metastatic melanoma
M Di Nicola et al.
CLINICAL CANCER RESEARCH (2004)
Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Cutting edge:: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells
S Huber et al.
JOURNAL OF IMMUNOLOGY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
T Maier et al.
BLOOD (2003)
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
JW Friedberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
JM Timmerman et al.
BLOOD (2002)
Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity
HP Feng et al.
BLOOD (2001)
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
F Berard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
A Trojan et al.
NATURE MEDICINE (2000)
分享论文
